Medical Condition

psoriasis

Total Trials

13

Recruiting Now

13

Trial Phases

Phase 2, Phase 1, Phase 4

ClinicalMetric tracks all active clinical trials for psoriasis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — psoriasis Clinical Trials

How many clinical trials are currently recruiting for psoriasis?

ClinicalMetric currently tracks 13 actively recruiting clinical trials for psoriasis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for psoriasis?

psoriasis research spans Phase 1 (3 trials), Phase 2 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a psoriasis clinical trial?

Eligibility criteria for psoriasis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Clarent Biopharma, Inc. 1 trial

Universitätsklinikum Hamburg-Eppendorf 1 trial

Islamia University of Bahawalpur 1 trial

Merck Sharp & Dohme LLC 1 trial

Royal United Hospitals Bath NHS Foundation Trust 1 trial

Recruiting Clinical Trials

NCT07204639 Phase 2

Recruiting

Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

Clarent Biopharma, Inc.

View Trial →

NCT01848028

Recruiting

PsoBest - The German Psoriasis Registry

Universitätsklinikum Hamburg-E...

View Trial →

NCT07615257

Recruiting

Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

Islamia University of Bahawalp...

View Trial →

NCT07850310 Phase 1

Recruiting

A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)

Merck Sharp & Dohme LLC

View Trial →

NCT07187817

Recruiting

SEquential Treatment of PSoriasis With Biologics

Royal United Hospitals Bath NH...

View Trial →

NCT05270733 Phase 4

Recruiting

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

University Hospitals Cleveland...

View Trial →

NCT07471048

Recruiting

A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Multi-Center PAMPA Study

Enrollment

176 pts

Location

United States, Canad...

Dietary Approach to Mild-to-moderate Psoriasis

University of Palermo

View Trial →

NCT05858528

Recruiting

HIPPOCRATES Prospective Observational Study

Immunoclassification of Psoriasis: a Strategy for Precision Medicine

Second Affiliated Hospital, Zh...

View Trial →

NCT03816345 Phase 1

Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Enrollment

300 pts

Location

United States, Canad...

Sponsor

National Cancer Institute (NCI...

View Trial →

Related Conditions

psoriatic arthritis (3) healthy (1) gluten sensitivity (1) immunoclassification (1) autoimmune disease (1) crohn disease (1) dermatomyositis (1) hematopoietic and lymphoid cell neoplasm (1) inflammatory bowel disease (1) malignant solid neoplasm (1) multiple sclerosis (1) rheumatoid arthritis (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology